 | • レポートコード：MRC2-11QY11213 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバーキットリンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バーキットリンパ腫治療の競争状況、市場シェア ・世界のバーキットリンパ腫治療市場：種類別市場規模 2015年-2020年（ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他） ・世界のバーキットリンパ腫治療市場：種類別市場規模予測 2021年-2026年（ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他） ・世界のバーキットリンパ腫治療市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界のバーキットリンパ腫治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米のバーキットリンパ腫治療市場分析：米国、カナダ ・ヨーロッパのバーキットリンパ腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバーキットリンパ腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバーキットリンパ腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバーキットリンパ腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc、Arvinas, Inc.、bluebird bio, Inc.、Boehringer Ingelheim GmbH、Constellation Pharmaceuticals, Inc.、Immunomedics, Inc.、Karyopharm Therapeutics, Inc.、Millennium Pharmaceuticals Inc、Patrys Limited、Seattle Genetics, Inc.、Takeda Pharmaceutical Company Limited、Theravectys SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Burkitt Lymphoma Treatment Market
The global Burkitt Lymphoma Treatment market size is projected to reach US$ 727 million by 2026, from US$ 708.4 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Burkitt Lymphoma Treatment Scope and Market Size
Burkitt Lymphoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Burkitt Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie Inc
Arvinas, Inc.
bluebird bio, Inc.
Boehringer Ingelheim GmbH
Constellation Pharmaceuticals, Inc.
Immunomedics, Inc.
Karyopharm Therapeutics, Inc.
Millennium Pharmaceuticals Inc
Patrys Limited
Seattle Genetics, Inc.
Takeda Pharmaceutical Company Limited
Theravectys SA
Market segment by Type, the product can be split into
ARV-825
Alisertib
bb-2121
Ibrutinib
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Burkitt Lymphoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Burkitt Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ARV-825
1.4.3 Alisertib
1.4.4 bb-2121
1.4.5 Ibrutinib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Burkitt Lymphoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Burkitt Lymphoma Treatment Market Perspective (2015-2026)
2.2 Global Burkitt Lymphoma Treatment Growth Trends by Regions
2.2.1 Burkitt Lymphoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Burkitt Lymphoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Burkitt Lymphoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Burkitt Lymphoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Burkitt Lymphoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Burkitt Lymphoma Treatment Players by Market Size
3.1.1 Global Top Burkitt Lymphoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Burkitt Lymphoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Burkitt Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Burkitt Lymphoma Treatment Market Concentration Ratio
3.2.1 Global Burkitt Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Burkitt Lymphoma Treatment Revenue in 2019
3.3 Burkitt Lymphoma Treatment Key Players Head office and Area Served
3.4 Key Players Burkitt Lymphoma Treatment Product Solution and Service
3.5 Date of Enter into Burkitt Lymphoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Burkitt Lymphoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Burkitt Lymphoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
5.2 Global Burkitt Lymphoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Burkitt Lymphoma Treatment Market Size (2015-2020)
6.2 Burkitt Lymphoma Treatment Key Players in North America (2019-2020)
6.3 North America Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
6.4 North America Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Burkitt Lymphoma Treatment Market Size (2015-2020)
7.2 Burkitt Lymphoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
7.4 Europe Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Burkitt Lymphoma Treatment Market Size (2015-2020)
8.2 Burkitt Lymphoma Treatment Key Players in China (2019-2020)
8.3 China Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
8.4 China Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Burkitt Lymphoma Treatment Market Size (2015-2020)
9.2 Burkitt Lymphoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
9.4 Japan Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Burkitt Lymphoma Treatment Market Size (2015-2020)
10.2 Burkitt Lymphoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Burkitt Lymphoma Treatment Market Size (2015-2020)
11.2 Burkitt Lymphoma Treatment Key Players in India (2019-2020)
11.3 India Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
11.4 India Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Burkitt Lymphoma Treatment Market Size (2015-2020)
12.2 Burkitt Lymphoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Burkitt Lymphoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Burkitt Lymphoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Details
13.1.2 AbbVie Inc Business Overview
13.1.3 AbbVie Inc Burkitt Lymphoma Treatment Introduction
13.1.4 AbbVie Inc Revenue in Burkitt Lymphoma Treatment Business (2015-2020))
13.1.5 AbbVie Inc Recent Development
13.2 Arvinas, Inc.
13.2.1 Arvinas, Inc. Company Details
13.2.2 Arvinas, Inc. Business Overview
13.2.3 Arvinas, Inc. Burkitt Lymphoma Treatment Introduction
13.2.4 Arvinas, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.2.5 Arvinas, Inc. Recent Development
13.3 bluebird bio, Inc.
13.3.1 bluebird bio, Inc. Company Details
13.3.2 bluebird bio, Inc. Business Overview
13.3.3 bluebird bio, Inc. Burkitt Lymphoma Treatment Introduction
13.3.4 bluebird bio, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.3.5 bluebird bio, Inc. Recent Development
13.4 Boehringer Ingelheim GmbH
13.4.1 Boehringer Ingelheim GmbH Company Details
13.4.2 Boehringer Ingelheim GmbH Business Overview
13.4.3 Boehringer Ingelheim GmbH Burkitt Lymphoma Treatment Introduction
13.4.4 Boehringer Ingelheim GmbH Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.4.5 Boehringer Ingelheim GmbH Recent Development
13.5 Constellation Pharmaceuticals, Inc.
13.5.1 Constellation Pharmaceuticals, Inc. Company Details
13.5.2 Constellation Pharmaceuticals, Inc. Business Overview
13.5.3 Constellation Pharmaceuticals, Inc. Burkitt Lymphoma Treatment Introduction
13.5.4 Constellation Pharmaceuticals, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.5.5 Constellation Pharmaceuticals, Inc. Recent Development
13.6 Immunomedics, Inc.
13.6.1 Immunomedics, Inc. Company Details
13.6.2 Immunomedics, Inc. Business Overview
13.6.3 Immunomedics, Inc. Burkitt Lymphoma Treatment Introduction
13.6.4 Immunomedics, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.6.5 Immunomedics, Inc. Recent Development
13.7 Karyopharm Therapeutics, Inc.
13.7.1 Karyopharm Therapeutics, Inc. Company Details
13.7.2 Karyopharm Therapeutics, Inc. Business Overview
13.7.3 Karyopharm Therapeutics, Inc. Burkitt Lymphoma Treatment Introduction
13.7.4 Karyopharm Therapeutics, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.7.5 Karyopharm Therapeutics, Inc. Recent Development
13.8 Millennium Pharmaceuticals Inc
13.8.1 Millennium Pharmaceuticals Inc Company Details
13.8.2 Millennium Pharmaceuticals Inc Business Overview
13.8.3 Millennium Pharmaceuticals Inc Burkitt Lymphoma Treatment Introduction
13.8.4 Millennium Pharmaceuticals Inc Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.8.5 Millennium Pharmaceuticals Inc Recent Development
13.9 Patrys Limited
13.9.1 Patrys Limited Company Details
13.9.2 Patrys Limited Business Overview
13.9.3 Patrys Limited Burkitt Lymphoma Treatment Introduction
13.9.4 Patrys Limited Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.9.5 Patrys Limited Recent Development
13.10 Seattle Genetics, Inc.
13.10.1 Seattle Genetics, Inc. Company Details
13.10.2 Seattle Genetics, Inc. Business Overview
13.10.3 Seattle Genetics, Inc. Burkitt Lymphoma Treatment Introduction
13.10.4 Seattle Genetics, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
13.10.5 Seattle Genetics, Inc. Recent Development
13.11 Takeda Pharmaceutical Company Limited
10.11.1 Takeda Pharmaceutical Company Limited Company Details
10.11.2 Takeda Pharmaceutical Company Limited Business Overview
10.11.3 Takeda Pharmaceutical Company Limited Burkitt Lymphoma Treatment Introduction
10.11.4 Takeda Pharmaceutical Company Limited Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
10.11.5 Takeda Pharmaceutical Company Limited Recent Development
13.12 Theravectys SA
10.12.1 Theravectys SA Company Details
10.12.2 Theravectys SA Business Overview
10.12.3 Theravectys SA Burkitt Lymphoma Treatment Introduction
10.12.4 Theravectys SA Revenue in Burkitt Lymphoma Treatment Business (2015-2020)
10.12.5 Theravectys SA Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Burkitt Lymphoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Burkitt Lymphoma Treatment Revenue
Table 3. Ranking of Global Top Burkitt Lymphoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Burkitt Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ARV-825
Table 6. Key Players of Alisertib
Table 7. Key Players of bb-2121
Table 8. Key Players of Ibrutinib
Table 9. Key Players of Others
Table 10. Global Burkitt Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Burkitt Lymphoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Burkitt Lymphoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Burkitt Lymphoma Treatment Market Share by Regions (2015-2020)
Table 14. Global Burkitt Lymphoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Burkitt Lymphoma Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Burkitt Lymphoma Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Burkitt Lymphoma Treatment Players
Table 21. Global Burkitt Lymphoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Burkitt Lymphoma Treatment Market Share by Players (2015-2020)
Table 23. Global Top Burkitt Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Burkitt Lymphoma Treatment as of 2019)
Table 24. Global Burkitt Lymphoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Burkitt Lymphoma Treatment Product Solution and Service
Table 27. Date of Enter into Burkitt Lymphoma Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Burkitt Lymphoma Treatment Market Size Share by Type (2015-2020)
Table 31. Global Burkitt Lymphoma Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Burkitt Lymphoma Treatment Market Size Share by Application (2015-2020)
Table 33. Global Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Burkitt Lymphoma Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 37. North America Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 39. North America Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 43. Europe Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 45. Europe Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 49. China Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 51. China Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 55. Japan Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 57. Japan Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 61. Southeast Asia Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 67. India Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 69. India Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Burkitt Lymphoma Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Burkitt Lymphoma Treatment Market Share (2019-2020)
Table 73. Central & South America Burkitt Lymphoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Burkitt Lymphoma Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Burkitt Lymphoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Burkitt Lymphoma Treatment Market Share by Application (2015-2020)
Table 77. AbbVie Inc Company Details
Table 78. AbbVie Inc Business Overview
Table 79. AbbVie Inc Product
Table 80. AbbVie Inc Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 81. AbbVie Inc Recent Development
Table 82. Arvinas, Inc. Company Details
Table 83. Arvinas, Inc. Business Overview
Table 84. Arvinas, Inc. Product
Table 85. Arvinas, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 86. Arvinas, Inc. Recent Development
Table 87. bluebird bio, Inc. Company Details
Table 88. bluebird bio, Inc. Business Overview
Table 89. bluebird bio, Inc. Product
Table 90. bluebird bio, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 91. bluebird bio, Inc. Recent Development
Table 92. Boehringer Ingelheim GmbH Company Details
Table 93. Boehringer Ingelheim GmbH Business Overview
Table 94. Boehringer Ingelheim GmbH Product
Table 95. Boehringer Ingelheim GmbH Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 96. Boehringer Ingelheim GmbH Recent Development
Table 97. Constellation Pharmaceuticals, Inc. Company Details
Table 98. Constellation Pharmaceuticals, Inc. Business Overview
Table 99. Constellation Pharmaceuticals, Inc. Product
Table 100. Constellation Pharmaceuticals, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 101. Constellation Pharmaceuticals, Inc. Recent Development
Table 102. Immunomedics, Inc. Company Details
Table 103. Immunomedics, Inc. Business Overview
Table 104. Immunomedics, Inc. Product
Table 105. Immunomedics, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 106. Immunomedics, Inc. Recent Development
Table 107. Karyopharm Therapeutics, Inc. Company Details
Table 108. Karyopharm Therapeutics, Inc. Business Overview
Table 109. Karyopharm Therapeutics, Inc. Product
Table 110. Karyopharm Therapeutics, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 111. Karyopharm Therapeutics, Inc. Recent Development
Table 112. Millennium Pharmaceuticals Inc Business Overview
Table 113. Millennium Pharmaceuticals Inc Product
Table 114. Millennium Pharmaceuticals Inc Company Details
Table 115. Millennium Pharmaceuticals Inc Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 116. Millennium Pharmaceuticals Inc Recent Development
Table 117. Patrys Limited Company Details
Table 118. Patrys Limited Business Overview
Table 119. Patrys Limited Product
Table 120. Patrys Limited Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 121. Patrys Limited Recent Development
Table 122. Seattle Genetics, Inc. Company Details
Table 123. Seattle Genetics, Inc. Business Overview
Table 124. Seattle Genetics, Inc. Product
Table 125. Seattle Genetics, Inc. Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 126. Seattle Genetics, Inc. Recent Development
Table 127. Takeda Pharmaceutical Company Limited Company Details
Table 128. Takeda Pharmaceutical Company Limited Business Overview
Table 129. Takeda Pharmaceutical Company Limited Product
Table 130. Takeda Pharmaceutical Company Limited Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 131. Takeda Pharmaceutical Company Limited Recent Development
Table 132. Theravectys SA Company Details
Table 133. Theravectys SA Business Overview
Table 134. Theravectys SA Product
Table 135. Theravectys SA Revenue in Burkitt Lymphoma Treatment Business (2015-2020) (Million US$)
Table 136. Theravectys SA Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Burkitt Lymphoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. ARV-825 Features
Figure 3. Alisertib Features
Figure 4. bb-2121 Features
Figure 5. Ibrutinib Features
Figure 6. Others Features
Figure 7. Global Burkitt Lymphoma Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Burkitt Lymphoma Treatment Report Years Considered
Figure 12. Global Burkitt Lymphoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Burkitt Lymphoma Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Burkitt Lymphoma Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Burkitt Lymphoma Treatment Market Share by Players in 2019
Figure 17. Global Top Burkitt Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Burkitt Lymphoma Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Burkitt Lymphoma Treatment Revenue in 2019
Figure 19. North America Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Burkitt Lymphoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
バーキットリンパ腫治療薬の世界市場（～2026年） Burn is an injury to skin or any tissue of body due to excessive heat, radiation, radioactivity, electricity, or contact with chemical materials. Burns are a serious problem across the globe and the World Health Organization estimates that it results in more than 265,000 deaths occur annually. Moreo…- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- 非ホジキンリンパ腫（NHL）の世界市場（～2026年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…
- 濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…